- 501-1000 Employees
- Based in Cambridge, Massachusetts
Moderna scientists designed the company’s prophylactic vaccines modality to prevent infectious diseases. More than 1,900 participants, prior to enrolling the Phase 3 study of mRNA-1273, have been enrolled in Moderna’s infectious disease vaccine clinical studies under health authorities in the U.S., Europe and Australia. Clinical data demonstrate that Moderna’s proprietary vaccine technology…More
Most Recent Responsibility Report
2022 ESG Report
Report Locked. Moderna Inc. has reached its limit for free report views.
Moderna Inc. does not currently have any hardcopy reports on ResponsibilityReports.com. Click the button below to request a report when hardcopies become available.
Please fill out the form below and click "Place Order" to complete your order.
Archived Responsibility Reports
Our service enables potential investors to review the most recent and archived Moderna Inc. Sustainability Report, Moderna Inc. Corporate Social Responsibility Report, Moderna Inc. CSR Report, Moderna Inc. Corporate Responsibility, Moderna Inc. CR Report, Moderna Inc. Citizenship Report, Moderna Inc. ESG Report, and Moderna Inc. Environmental Report online.